hCB2R potency and predicted log D7.4 of fluorescent probes 12–18.
Cmpd | EC50 or IC50a (nM) | E max b (%) | Function | Parent cmpds | Dye | c log D7.4c |
---|---|---|---|---|---|---|
12 | 82 | 80 | Partial agonist | 1/10b | TAMRA | 3.7 |
13 | 528 | 127 | Full agonist | 1/10b | SiR | 3.9 |
14 | 77 | 79 | Partial agonist | 1/10b | Alexa488 | −0.5 |
15 | 523 | 129 | Full agonist | 1/10b | Alexa467 | −0.9 |
16 | 114 | −29 | Inverse agonist | 2/11b | TAMRA | 3.6 |
17 | 129 | −29 | Inverse agonist | 2/11b | SiR | 2.2 |
18 | 262 | −26 | Inverse agonist | 2/11b | Alexa488 | −0.9 |
The potency (EC50 or IC50) of fluorescent probes 12–18 was measured using cells stably expressing hCB2R in homogeneous time-resolved fluorescence (HTRF) cAMP assay. The data are the means of four or seven independent experiments performed in technical replicates.
Maximum effect (Emax in %) was normalized to reference full agonist APD371.
For computational calculation of c log D7.4 see ref. 36.